175 related articles for article (PubMed ID: 28714104)
1. Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
Li XF; Chen C; Xiang DM; Qu L; Sun W; Lu XY; Zhou TF; Chen SZ; Ning BF; Cheng Z; Xia MY; Shen WF; Yang W; Wen W; Lee TKW; Cong WM; Wang HY; Ding J
Hepatology; 2017 Dec; 66(6):1934-1951. PubMed ID: 28714104
[TBL] [Abstract][Full Text] [Related]
2. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
3. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.
Hung MH; Tai WT; Shiau CW; Chen KF
World J Gastroenterol; 2014 Nov; 20(41):15269-74. PubMed ID: 25386075
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between heat shock factor 1 and signal transducer and activator of transcription 3 mediated by interleukin-8 autocrine signaling maintains the cancer stem cell phenotype in liver cancer.
Yang Z; Wan W; Zhang P; Wang S; Zhao Z; Xue J; Yao M; Zhao Y; Zheng W; Niu B; Wang M; Li H; Guo W; Ren Z; Hu Y
J Gastroenterol Hepatol; 2023 Jan; 38(1):138-152. PubMed ID: 36300571
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT.
Mao J; Yang H; Cui T; Pan P; Kabir N; Chen D; Ma J; Chen X; Chen Y; Yang Y
Eur J Pharmacol; 2018 Aug; 832():39-49. PubMed ID: 29782854
[TBL] [Abstract][Full Text] [Related]
8. To be or not to be: The double-edged sword roles of liver progenitor cells.
Yan ZJ; Chen L; Wang HY
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188870. PubMed ID: 36842766
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 programs liver progenitor cell transformation into cancer stem cells through miR-122 downregulation with increased risk of primary liver cancer initiation.
Gasmi I; Machou C; Rodrigues A; Brouillet A; Nguyen TC; Rousseau B; Guillot A; Rodriguez C; Demontant V; Ait-Ahmed Y; Calderaro J; Luciani A; Pawlotsky JM; Lafdil F
Int J Biol Sci; 2022; 18(5):1944-1960. PubMed ID: 35342340
[TBL] [Abstract][Full Text] [Related]
10. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification.
Liu C; Liu L; Shan J; Shen J; Xu Y; Zhang Q; Yang Z; Wu L; Xia F; Bie P; Cui Y; Zhang X; Bian X; Qian C
Cancer Lett; 2013 Oct; 339(1):60-9. PubMed ID: 23879963
[TBL] [Abstract][Full Text] [Related]
12. CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
Zeng C; Zhang Y; Park SC; Eun JR; Nguyen NT; Tschudy-Seney B; Jung YJ; Theise ND; Zern MA; Duan Y
Stem Cells Dev; 2015 Nov; 24(21):2467-78. PubMed ID: 26192559
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection.
Feng D; Kong X; Weng H; Park O; Wang H; Dooley S; Gershwin ME; Gao B
Gastroenterology; 2012 Jul; 143(1):188-98.e7. PubMed ID: 22484119
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.
Sprinzl MF; Reisinger F; Puschnik A; Ringelhan M; Ackermann K; Hartmann D; Schiemann M; Weinmann A; Galle PR; Schuchmann M; Friess H; Otto G; Heikenwalder M; Protzer U
Hepatology; 2013 Jun; 57(6):2358-68. PubMed ID: 23424039
[TBL] [Abstract][Full Text] [Related]
15. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
Li R; Yanjiao G; Wubin H; Yue W; Jianhua H; Huachuan Z; Rongjian S; Zhidong L
Oncotarget; 2017 Mar; 8(12):19354-19364. PubMed ID: 28423613
[TBL] [Abstract][Full Text] [Related]
16. Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury.
Viebahn CS; Benseler V; Holz LE; Elsegood CL; Vo M; Bertolino P; Ganss R; Yeoh GC
J Hepatol; 2010 Sep; 53(3):500-7. PubMed ID: 20561705
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.
Tai WT; Shiau CW; Chen PJ; Chu PY; Huang HP; Liu CY; Huang JW; Chen KF
Hepatology; 2014 Jan; 59(1):190-201. PubMed ID: 23908138
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.
Bogaerts E; Heindryckx F; Devisscher L; Paridaens A; Vandewynckel YP; Van den Bussche A; Verhelst X; Libbrecht L; van Grunsven LA; Geerts A; Van Vlierberghe H
PLoS One; 2015; 10(3):e0119555. PubMed ID: 25793288
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of gp130-mediated STAT-3 and ERK-1/ 2 signaling in liver progenitor cell migration and proliferation.
Yeoh GC; Ernst M; Rose-John S; Akhurst B; Payne C; Long S; Alexander W; Croker B; Grail D; Matthews VB
Hepatology; 2007 Feb; 45(2):486-94. PubMed ID: 17256754
[TBL] [Abstract][Full Text] [Related]
20. [Suppression of the growth of subcutaneous transplanted human liver cancer and lung metastasis in nude mice treated by sorafenib combined with fluorouracil].
Shen HJ; Wang YH; Xu J
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):98-102. PubMed ID: 23714662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
